Company

Built to de-risk, not to promise.

BioUnbound Inc. is a Delaware development-stage company built around two oral delivery platforms for peptide and metabolic medicines.

How we work

A lean company, with specialist partners.

A small core team

The founders lead strategy and science directly. Capital goes into validation and manufacturing rather than an internal build-out.

Established manufacturers

Development and manufacturing are contracted to organizations that already produce oral films and softgels at commercial scale.

Milestones before claims

Each program advances on measured results, reviewed against criteria set in advance.

Leadership

Operators who have run regulated programs before.

Chief Executive Officer and co-founder

Alan Joslyn, PhD

More than thirty years of pharmaceutical leadership, including service as chairman and chief executive of Inimmune, president and chief executive of Oragenics, a director of Synergy Pharmaceuticals, and a worldwide product leader at Johnson & Johnson.

Chief Science Officer and co-founder

Del Potter, PhD

Inventor of the BioUnbound delivery platform. Joint UCSF and UC Berkeley PhD in neuropharmacology, with four decades in pharmaceutical formulation and delivery science, including work with 3M and Catalent, and direction of Phase 1 and Phase 2 clinical trials.

Contact

Let’s explore what comes next.

For company information, partnership discussions, or investor and media enquiries, connect with the BioUnbound team.